Research news

Congratulations to UCLH’s Dr Mary McCormack who has been listed as one of the 100 most influential people in health in the world by TIME magazine.

A new research project spearheaded by the CCTU at UCLH is trying to make more places on clinical trials available to young cancer patients aged between 16 and 24 years.

A new research project aims to improve understanding of the unique impact of health conditions on UK Black communities.

Newly reported updated results of a study from UCLH and UCL highlights the powerful benefits of a targeted immune therapy for a type of slow-growing blood cancer.

UCLH has recruited the first participant in Europe to a global clinical trial for adults with Myotonic Dystrophy Type 1 (DM1)- a genetic condition and type of muscular dystrophy that causes progressive muscle weakness and wasting.